Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024 PARIS ... ADVERSE REACTIONS ALGS: The most common adverse reactions (>5%) are ...
A largely cloudy day with periods of rain – persistent and fairly heavy at times across Devon and Cornwall – with drier spells most likely in ... Rain arriving after dark with snow over hills and ...